Replies to post #35639 on RespireRx Pharmaceuticals Inc (fka RSPI)

[RBlatch45]

A five month extended overdue wait... for this release.

It is no wonder that our nation has seen better days. Really...?

Cordially,
RBlatch

[alertmeipp]

The funny thing about this is we have been waiting for this for so long and now it's out - we don't know whether it's good or not.

Well, the principal investigator said worth to move on to test in bigger trial. WHATEVER.

[davidal66]

Again, the test augers well for ADHD. Very well for RD and especially for ADHD. I believe this effect of insomnia as reported in the CX717 study/and contracted, less sleep, in the apnea study strongly suggests a class effect in ADHD and disorders related therein. Keep in mind, the ampakine here was administered late in the day, but in the ADHD trial the ampakine would be given early in the day. This doesn't change the management status or cash on hand status or stock price status(immediately), but is indicative of a bullseye in ADHD and RD in my book.

[haysaw]

With folks like Pfizer continuing to slash and burn RD it's anyone's guess if there are willing partners

There is another way to look at this: With PFE and others drastically cutting R&D and staff, there must be a tremendous pool of ambitious, well-connected managerial candidates hitting the streets. The time has come for change here (actually, it's been time for years), but mgmt will suppress any awareness of their incompetence, just as certain experts continue to do. There are many layers to this tragic story, and there is bound to be more on the horizon, if the past is any indication.